BIBLIOGRAPHIC RECORD

A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Helen Heussler; Jonathan Cohen; Natalie Silove; Nancy Tich; Marcel O. Bonn‐Miller; Wei Du; Carol S. O'Neill; Terri B. Sebree
Source of metadata
OpenAlex
Year recorded
2019

Public identifiers and source

Open the source record

Reference

Helen Heussler; Jonathan Cohen; Natalie Silove; Nancy Tich; Marcel O. Bonn‐Miller; Wei Du; Carol S. O'Neill; Terri B. Sebree. (2019). A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome. https://openalex.org/W2965554962

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-394662d4fe69d6c278520168c060d7b6/